A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial
Tabernero, J., Yoshino, T., Stintzing, S., de Gramont, A., Gibbs, P., Jonker, D. J., . . . Lenz, H. J. … Read More